165 related articles for article (PubMed ID: 37138538)
1. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA-29-5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease.
Brundin M; Wågsäter D; Alehagen U; Carlhäll CJ
ESC Heart Fail; 2021 Oct; 8(5):3865-3874. PubMed ID: 34173728
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy.
Zaragoza C; Saura M; Hernández I; Ramirez-Carracedo R; García-García F; Zamorano JL; Mangas A; Toro R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792263
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.
Fan KL; Zhang HF; Shen J; Zhang Q; Li XL
Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607
[TBL] [Abstract][Full Text] [Related]
6. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
7. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
8. A Kaposi's sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy.
Zhao Y; Li H; Du H; Yin Z; He M; Fan J; Nie X; Sun Y; Hou H; Dai B; Zhang X; Cai Y; Jin K; Ding N; Wen Z; Chang J; Chen C; Wang DW
Signal Transduct Target Ther; 2023 Jun; 8(1):226. PubMed ID: 37291118
[TBL] [Abstract][Full Text] [Related]
9. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy.
Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z
Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Etiology of Dilated Cardiomyopathy through Differential miRNA-mRNA Interactome.
Bonet F; Hernandez-Torres F; Ramos-Sánchez M; Quezada-Feijoo M; Bermúdez-García A; Daroca T; Alonso-Villa E; García-Padilla C; Mangas A; Toro R
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785931
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice.
Wang T; Yuan L; Chen Y; Wang J; Li N; Zhou H
Genes Genomics; 2023 Aug; 45(8):1003-1011. PubMed ID: 37253907
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNA as novel markers for diastolic dysfunction.
Nair N; Kumar S; Gongora E; Gupta S
Mol Cell Biochem; 2013 Apr; 376(1-2):33-40. PubMed ID: 23247724
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
[TBL] [Abstract][Full Text] [Related]
18. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1.
Zhu Y; Yang X; Zhou J; Chen L; Zuo P; Chen L; Jiang L; Li T; Wang D; Xu Y; Li Q; Yan Y
Oxid Med Cell Longev; 2022; 2022():3182931. PubMed ID: 35126811
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy.
Feng Y; Xu W; Zhang W; Wang W; Liu T; Zhou X
Theranostics; 2019; 9(15):4558-4566. PubMed ID: 31285779
[No Abstract] [Full Text] [Related]
20. miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis.
Xia X; Liang Y; Zheng W; Lin D; Sun S
Mol Cell Probes; 2020 Aug; 52():101558. PubMed ID: 32145290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
